Gan T J, Ginsberg B, Grant A P, Glass P S
Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Anesthesiology. 1996 Nov;85(5):1036-42. doi: 10.1097/00000542-199611000-00011.
Breast surgery is associated with a high incidence of postoperative nausea and vomiting. Propofol and prophylactic administration of ondansetron are associated with a lower incidence of postoperative nausea and vomiting. To date no comparison of these two drugs has been reported. A randomized study was done to compare the efficacy of ondansetron and intraoperative propofol given in various regimens.
Study participants included 89 women classified as American Society of Anesthesiologists physical status 1 or 2 who were scheduled for major breast surgery. Patients were randomly assigned to one of four groups. Group O received 4 mg ondansetron in 10 ml 0.9% saline and groups PI, PIP, and PP received 10 ml 0.9% saline before anesthesia induction. Group O received thiopental, isoflurane, nitrous oxide-oxygen, and fentanyl for anesthesia. Group PI received propofol, isoflurane, nitrous oxide-oxygen, and fentanyl. Group PIP received propofol, isoflurane, nitrous oxide-oxygen, and fentanyl. Thirty minutes before expected skin closure, isoflurane was discontinued and 50 to 150 micrograms.kg-1.min-1 propofol was given intravenously to maintain anesthesia. Group PP received propofol for induction and maintenance of anesthesia, nitrous oxide-oxygen, and fentanyl. Postoperative pain relief was provided with morphine administered by a patient-controlled analgesia pump. The incidence of nausea and vomiting, requests for rescue antiemetic and sedation, pain scores, and hemodynamic data were recorded for 24 h.
Within 6 h of surgery, groups O and PP had a lower incidence of nausea compared with groups PI and PIP (P < 0.05). Fewer patients in group PP (19%) vomited during the 24-h period compared with groups O (48%), PI (64%), and PIP (52%) (P < 0.05). The incidence of antiemetic use was also less in group PP (P < 0.05). Patients in group PP had lower sedation scores at 30 min and at 1 h (P < 0.05). There were no differences among the groups in pain scores, blood pressure, heart rate, respiratory rate, and incidence of pruritus.
Propofol administered to induce and maintain anesthesia is more effective than ondansetron (with thiopental-isoflurane anesthesia) in preventing postoperative vomiting and is associated with fewer requests for rescue antiemetic and sedation in the early phase of recovery. It is equally effective in preventing postoperative nausea as ondansetron in the first 6 h after operation. Propofol used only as an induction agent or for induction and at the end of surgery were not as protective against postoperative nausea and vomiting.
乳腺手术与术后恶心呕吐的高发生率相关。丙泊酚和预防性使用昂丹司琼与较低的术后恶心呕吐发生率相关。迄今为止,尚未有这两种药物的比较报道。进行了一项随机研究以比较不同给药方案下昂丹司琼和术中丙泊酚的疗效。
研究参与者包括89名美国麻醉医师协会身体状况为1或2级、计划进行大型乳腺手术的女性。患者被随机分配到四组中的一组。O组在10 ml 0.9% 生理盐水中给予4 mg昂丹司琼,PI组、PIP组和PP组在麻醉诱导前给予10 ml 0.9% 生理盐水。O组使用硫喷妥钠、异氟烷、氧化亚氮 - 氧气和芬太尼进行麻醉。PI组使用丙泊酚、异氟烷、氧化亚氮 - 氧气和芬太尼。PIP组使用丙泊酚、异氟烷、氧化亚氮 - 氧气和芬太尼。预计皮肤缝合前30分钟,停用异氟烷,静脉给予50至150微克·千克⁻¹·分钟⁻¹的丙泊酚以维持麻醉。PP组使用丙泊酚诱导和维持麻醉、氧化亚氮 - 氧气和芬太尼。术后通过患者自控镇痛泵给予吗啡缓解疼痛。记录24小时内恶心呕吐的发生率、抢救性使用止吐药和镇静药的情况、疼痛评分以及血流动力学数据。
在术后6小时内,O组和PP组的恶心发生率低于PI组和PIP组(P < 0.05)。与O组(48%)、PI组(64%)和PIP组(52%)相比,PP组在24小时内呕吐的患者较少(19%)(P < 0.05)。PP组止吐药的使用发生率也较低(P < 0.05)。PP组患者在30分钟和1小时时的镇静评分较低(P < 0.05)。各组之间在疼痛评分、血压、心率、呼吸频率和瘙痒发生率方面没有差异。
用于诱导和维持麻醉的丙泊酚在预防术后呕吐方面比昂丹司琼(联合硫喷妥钠 - 异氟烷麻醉)更有效,并且在恢复早期抢救性使用止吐药和镇静药的需求较少。在术后的前6小时内,其预防术后恶心的效果与昂丹司琼相同。仅用作诱导剂或在手术诱导和结束时使用丙泊酚对术后恶心呕吐的预防效果不佳。